Stock listing
NASDAQ:PRE Prenetics Global Limited Stock
Home listing (NASDAQ) of Prenetics Global Limited
Follow Prenetics Global Limited into a list and get an email when it puts out news.
Share price · NASDAQ:PRE
$8.80 USD -1.51 (-14.6%)
Close on Nov 20, 2026
- Day range
- $8.70 – $10.29 USDNov 20, 2026
- Volume
- 593,989 sharesNov 20, 2026
- Market cap
- $157.8M USDAt the close on Nov 20, 2026 · price × 17.93M shares outstanding
- 52-week range
- $8.70 – $27.24 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $5.00M USDMedian day 177,000 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PRE · Home | $8.80 USD | -1.51 (-14.6%) | 593,989 | $10.29 | $10.29 | $8.70 | $10.31 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:PRE · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $8.80 | -1.51 | -14.6% | $10.29 | $10.29 | $8.70 | 593,989 | |
| $10.31 | -0.04 | -0.4% | $10.32 | $11.79 | $9.69 | 820,940 | |
| $10.35 | -5.98 | -36.6% | $13.89 | $14.29 | $9.134 | 1,578,068 | |
| $16.33 | +0.85 | +5.5% | $15.50 | $16.72 | $15.33 | 218,368 | |
| $15.48 | -1.03 | -6.2% | $16.50 | $17.05 | $14.95 | 169,001 | |
| $16.51 | -0.21 | -1.3% | $16.47 | $17.74 | $16.30 | 151,800 | |
| $16.72 | -0.92 | -5.2% | $17.50 | $17.83 | $16.30 | 123,100 | |
| $17.64 | +0.41 | +2.4% | $17.84 | $18.40 | $17.58 | 148,700 | |
| $17.23 | -0.32 | -1.8% | $17.39 | $18.45 | $17.11 | 150,300 | |
| $17.55 | +1.61 | +10.1% | $16.08 | $17.93 | $16.08 | 286,200 | |
| $15.94 | -0.18 | -1.1% | $15.53 | $16.38 | $15.21 | 100,700 | |
| $16.12 | +0.08 | +0.5% | $16.25 | $16.60 | $14.69 | 341,000 | |
| $16.04 | -0.15 | -0.9% | $16.10 | $16.41 | $15.76 | 174,700 | |
| $16.19 | -0.28 | -1.7% | $16.75 | $17.11 | $16.08 | 92,400 | |
| $16.47 | -1.29 | -7.3% | $18.10 | $18.28 | $15.76 | 266,300 | |
| $17.76 | -1.22 | -6.4% | $18.75 | $18.89 | $17.30 | 101,900 | |
| $18.98 | +0.46 | +2.5% | $18.38 | $19.28 | $18.34 | 103,700 | |
| $18.52 | +0.09 | +0.5% | $18.49 | $18.87 | $18.19 | 118,100 | |
| $18.43 | +0.06 | +0.3% | $18.35 | $19.05 | $17.90 | 249,500 | |
| $18.37 | +1.02 | +5.9% | $17.84 | $18.72 | $17.84 | 115,800 | |
| $17.35 | +0.78 | +4.7% | $16.82 | $17.85 | $16.81 | 160,600 | |
| $16.57 | -0.16 | -1.0% | $16.78 | $17.56 | $16.03 | 290,300 | |
| $16.73 | -1.90 | -10.2% | $18.98 | $18.98 | $16.35 | 292,400 | |
| $18.63 | -0.39 | -2.1% | $19.04 | $19.88 | $18.55 | 92,900 | |
| $19.02 | +0.50 | +2.7% | $18.75 | $19.63 | $18.01 | 167,700 | |
| $18.52 | -1.74 | -8.6% | $20.11 | $20.38 | $18.05 | 334,700 | |
| $20.26 | -0.34 | -1.7% | $20.30 | $20.99 | $20.15 | 93,300 | |
| $20.60 | -0.67 | -3.1% | $21.30 | $21.64 | $20.40 | 154,500 | |
| $21.27 | +0.11 | +0.5% | $21.16 | $21.52 | $20.49 | 96,500 | |
| $21.16 | -0.68 | -3.1% | $21.10 | $21.66 | $20.71 | 143,500 | |
| $21.84 | -0.16 | -0.7% | $22.01 | $22.40 | $20.91 | 136,000 | |
| $22.00 | -0.47 | -2.1% | $22.24 | $23.15 | $21.51 | 509,600 | |
| $22.47 | +2.07 | +10.1% | $20.40 | $22.80 | $20.35 | 283,400 | |
| $20.40 | -0.56 | -2.7% | $21.17 | $21.17 | $19.81 | 320,100 | |
| $20.96 | +0.79 | +3.9% | $20.64 | $21.36 | $20.10 | 156,400 | |
| $20.17 | -1.78 | -8.1% | $22.15 | $22.23 | $19.85 | 311,500 | |
| $21.95 | -1.18 | -5.1% | $23.28 | $23.60 | $21.89 | 89,400 | |
| $23.13 | +0.29 | +1.3% | $22.83 | $23.50 | $22.57 | 67,300 | |
| $22.84 | +0.08 | +0.4% | $22.98 | $23.22 | $22.69 | 65,900 | |
| $22.76 | -0.21 | -0.9% | $22.76 | $23.08 | $22.42 | 74,300 | |
| $22.97 | +0.04 | +0.2% | $22.63 | $23.69 | $22.22 | 136,900 | |
| $22.93 | +0.22 | +1.0% | $22.71 | $23.53 | $22.13 | 254,200 | |
| $22.71 | -0.19 | -0.8% | $22.95 | $23.55 | $22.35 | 245,800 | |
| $22.90 | -1.44 | -5.9% | $24.00 | $24.00 | $22.78 | 240,800 | |
| $24.34 | +0.15 | +0.6% | $24.70 | $25.01 | $23.76 | 112,700 | |
| $24.19 | 0.00 | 0.0% | $24.41 | $24.75 | $23.81 | 123,900 | |
| $24.19 | +2.17 | +9.9% | $21.65 | $24.93 | $21.65 | 279,600 | |
| $22.02 | -1.06 | -4.6% | $23.08 | $23.17 | $21.55 | 246,200 | |
| $23.08 | -1.04 | -4.3% | $24.04 | $24.04 | $23.02 | 179,300 | |
| $24.12 | +0.65 | +2.8% | $22.78 | $24.53 | $22.50 | 162,900 | |
| $23.47 | -0.19 | -0.8% | $23.78 | $23.90 | $22.95 | 143,900 | |
| $23.66 | -0.61 | -2.5% | $24.09 | $24.70 | $23.34 | 188,200 | |
| $24.27 | -1.35 | -5.3% | $25.50 | $25.96 | $23.93 | 251,700 | |
| $25.62 | +0.18 | +0.7% | $25.44 | $26.40 | $25.41 | 157,900 | |
| $25.44 | -0.19 | -0.7% | $25.63 | $26.02 | $25.13 | 105,700 | |
| $25.63 | -0.42 | -1.6% | $26.26 | $26.58 | $25.11 | 203,500 | |
| $26.05 | +0.24 | +0.9% | $25.96 | $27.24 | $25.65 | 336,500 | |
| $25.81 | -0.44 | -1.7% | $26.46 | $26.46 | $25.01 | 181,500 | |
| $26.25 | +0.49 | +1.9% | $25.84 | $26.70 | $25.76 | 196,900 | |
| $25.76 | -0.49 | -1.9% | $26.25 | $26.29 | $25.07 | 273,700 | |
| $26.25 | +0.47 | +1.8% | $25.55 | $26.50 | $24.62 | 952,600 | |
| $25.78 | +2.53 | +10.9% | $23.80 | $26.29 | $23.29 | 822,000 | |
| $23.25 | +1.43 | +6.6% | $22.17 | $23.50 | $22.00 | 525,900 | |
| $21.82 | +1.62 | +8.0% | $19.13 | $21.88 | $19.13 | 417,700 | |
| $20.20 | +2.23 | +12.4% | $17.40 | $20.50 | $17.40 | 329,000 | |
| $17.97 | -0.79 | -4.2% | $18.76 | $19.20 | $17.81 | 104,600 |
Splits
2 splits since 2022 · NASDAQ:PRE · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-15 | Consolidation | |
| 129-for-100 | Split |
- Ticker
- NASDAQ:PRE
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 18, 2026
Prenetics’ IM8 Reports Q3 2026 Revenue Growth of 266% YoY; Earliest Customers Have Returned More Than 3x Their Acquisition Cost in Under Two Years; Reaffirms FY 2026 Total Revenue Guidance of $220–230 Million and FY 2027 IM8 Revenue Guidance of $400 Million+
Latest earnings call · Nov 18, 2026
Prenetics Global (NASDAQ:PRE) Q4 2026 Earnings Call
Replay and transcript
Latest deck · Nov 18, 2026
Q3 2026 Earnings Presentation
Earnings · 70 slides
Latest news
Prenetics’ IM8 Reports Q3 2026 Revenue Growth of 266% YoY; Earliest Customers Have Returned More Than 3x Their Acquisition Cost in Under Two Years; Reaffirms FY 2026 Total Revenue Guidance of $220–230 Million and FY 2027 IM8 Revenue Guidance of $400 Million+
Nov 18, 2026
Closed $10.35 (-36.6%) on Nov 18, 2026
Prenetics’ IM8 Announces Three-Time GRAMMY-Winning DJ and Producer Diplo as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
Nov 16, 2026
Closed $15.48 (-6.2%) on Nov 16, 2026
Care Bears And Prenetics' IM8 Announce Global Partnership
Nov 5, 2026
Closed $16.12 (+0.5%) on Nov 5, 2026
Prenetics’ IM8 and Authentic Brands Group Announce 10-Year Exclusive Global Partnership to Create Care Bears by IM8; Authentic to Become Strategic Shareholder in Prenetics
Nov 5, 2026
Closed $16.12 (+0.5%) on Nov 5, 2026
Prenetics’ IM8 Names Brian J. Rosin as Successor Chief Financial Officer
Nov 3, 2026
Closed $16.19 (-1.7%) on Nov 3, 2026
Amendment to Annual Report by Foreign Issuer (Form 20-F/A)
Sep 4, 2026
Closed $25.44 (-0.7%) on Sep 4, 2026
Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
Aug 26, 2026
Closed $25.78 (+10.9%) on Aug 26, 2026
Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond
Aug 18, 2026
Closed $19.40 (+0.2%) on Aug 18, 2026
2Q26 Letter to Shareholders
Aug 18, 2026
Closed $19.40 (+0.2%) on Aug 18, 2026
Prenetics Global Limited on 6ix
- News releases
- 32 in the last 12 months · 80 in all · newest Nov 18, 2026 · oldest 2022
- Calls
- 5 calls with a replay · 5 with a transcript · latest Nov 18, 2026
- Decks
- 6 decks · latest Nov 18, 2026
Where Prenetics Global Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PRE · Home listing · This page | NASDAQ | United States | USD |
| BOATS:PRE | BOATS | United States | USD |
Valuation
Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $49.10M USD
- P/E
- Loss
- EV/sales
- 0.3×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 1.7×
- Gross margin
- 62.6%
- Operating margin
- −35.2%
- Net margin
- −47.4%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 1.78
Forecasts
6 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 36.22 USD · Analysts' mean
- EPS, year to Dec 2026
- -4.40 · 4 analysts
- Revenue, year to Dec 2026
- 222.9M · 9 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Danny Yeung | Director, Co-Founder & Chief Executive Officer |
| Brian Rosin | U.S. Chief Financial Officer |
| Brian Chae | General Counsel |
| Angela Cheung | Investor Relations / Corporate Finance |
| Robert Hester | VP of Growth |
| Samantha Kwok | Chief of Staff, VP, Operations & People |
| Senthil Sundaram | Chief Clinical Officer |
Board
| Director | Role |
|---|---|
| Ben Cheng | Independent Director, Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee |
| Caroline Levy | Independent Director |
| Danny Yeung | Director, Co-Founder & Chief Executive Officer |
| Darshan Shah | Independent Director |
| Hudson Leogrande | Independent Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Prenetics Global (NASDAQ:PRE) Q4 2026 Earnings Call | Wed, Nov 18, 2026 · 8:30 AM ET | Replay |
| Prenetics Global (NASDAQ:PRE) Q2 2026 Earnings Call | Tue, Aug 18, 2026 · 8:30 AM ET | Replay |
| Prenetics Global (NASDAQ:PRE) Q1 2026 Earnings Call | Thu, May 14, 2026 · 10:00 AM ET | Replay |
| Prenetics Global (NASDAQ:PRE) Q4 2025 Earnings Call | Wed, Feb 18, 2026 · 10:00 AM ET | Replay |
| Prenetics Global (NASDAQ:PRE) Q3 2025 Earnings Call | Mon, Nov 10, 2025 · 8:30 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Nov 18, 2026 · Before open | −36.6% |
| Q2 2026 | Aug 18, 2026 · Before open | +0.1% |
| Q1 2026 | Jun 10, 2026 | −1.1% |
| Q4 2025 | Feb 18, 2026 · Before open | −7.7% |
| Q3 2025 | Nov 10, 2025 | +4.8% |
| Q2 2025 | Sep 12, 2025 · Before open | +13.7% |
| Q1 2025 | Jun 12, 2025 · Before open | +5.5% |
| Q4 2024 | Mar 5, 2025 | −0.6% |
| Q3 2024 | Nov 27, 2024 · Before open | −1.6% |
| Q1 2024 | May 1, 2024 · Before open | −2.8% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Mar 12, 2024 | −6.4% |
| Q3 2023 | Nov 20, 2023 · Before open | +1.5% |
| Q2 2023 | Sep 15, 2023 · Before open | −2.0% |
| Q1 2023 | Jun 5, 2023 · Before open | +8.0% |
| Q4 2022 | Mar 14, 2023 · Before open | −6.4% |
| Q3 2022 | Nov 10, 2022 · Before open | +4.0% |
| Q2 2022 | Sep 9, 2022 · Before open | +11.8% |
| Q1 2022 | Jun 6, 2022 · Before open | 0.0% |
| Q4 2021 | Mar 4, 2022 · After close | −0.1% |
| Q3 2021 | Nov 15, 2021 | −0.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 70 slides | Nov 18, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 79 slides | Aug 18, 2026 |
| Investor Presentation (July 2026) | Investor deck | 13 slides | July 2026 |
| Q1 2026 Earnings Presentation | Earnings | 43 slides | June 2026 |
| Q1 2026 Earnings Presentation | Earnings | 42 slides | May 14, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 40 slides | Feb 18, 2026 |
Financings
| Raise | Date |
|---|---|
| Public offering of class A ordinary shares with Class A and Class B common warrants Closed: US$44M raised · US$16.08 a share · Warrants at US$24.12 for 60 months · Dominari Securities LLC Dealers: Dominari Securities LLC (lead) Use of proceeds: Global expansion of IM8 and strategic accumulation of Bitcoin | Oct 28, 2025 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 92.4M | 30.6M | 21.7M | 13.2M | 12.5M | 65.2M | 9.23M | 5.48B | 6.48B | 5.59B |
| Cost of revenue | 43.6M | 15.2M | 12.9M | 9.55M | 8.93M | 38.8M | 6.52M | 4.76B | 5.12B | 4.68B |
| Gross profit | 48.8M | 15.4M | 8.83M | 3.62M | 3.60M | 26.3M | 2.72M | 668.7M | 1.36B | 860.4M |
| Research and development | 5.13M | 10.9M | 11.7M | 5.99M | 6.39M | 2.78M | 2.99M | |||
| Selling, general and administrative | 45.7M | 46.7M | 41.4M | 59.3M | 47.9M | 16.6M | 13.2M | |||
| Operating income | -38.1M | -48.1M | -51.9M | -66.0M | -56.7M | -995.1K | -20.8M | 642.1M | 1.33B | 833.2M |
| Depreciation and amortization | 3.78M | 4.02M | 5.88M | 5.99M | 4.29M | 1.29M | 2.23M | |||
| EBITDA | -34.3M | -44.1M | -46.0M | -60.0M | -52.4M | 297.3K | -18.6M | |||
| Interest expense | 241.0K | 203.0K | 119.7K | 4.20M | 5.24M | 59.6K | 69.4K | 0 | 0 | 0 |
| Income before tax | -36.2M | -57.7M | -56.7M | -225.8M | -216.6M | -3.90M | -20.9M | 180.4M | 1.31B | 708.2M |
| Income tax | 34.0K | -7.87M | -269.0K | -245.0K | 2.57M | -1.94M | -677.5K | 79.7M | 239.5M | 48.4M |
| Net income | -37.7M | -46.3M | -62.7M | -190.5M | -174.0M | -1.94M | -20.1M | 104.4M | 1.05B | 664.0M |
| Earnings per share, basic | -2.68 | -3.71 | -5.58 | -37.57 | -178.81 | -0.15 | -2.72 | 11.86 | ||
| Earnings per share, diluted | -3.71 | -5.58 | -37.57 | -178.81 | -0.15 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 32.1M | 52.3M | 45.7M | 146.7M | 35.3M | 14.5M | 11.5M | 1.58B | 1.31B | 1.50B |
| Short-term investments | 29.4M | 10.6M | 27.0M | 37.5M | 9.91M | 314.7K | 294.1K | 629.1M | 390.1M | 467.0M |
| Receivables | 2.98M | 16.8M | 17.7M | 53.2M | 54.9M | 23.1M | 2.89M | |||
| Inventory | 7.06M | 6.57M | 3.13M | 4.53M | 6.83M | 4.50M | 547.9K | |||
| Current assets | 83.4M | 86.1M | 93.7M | 241.8M | 106.9M | 44.0M | 15.6M | |||
| Property, plant and equipment | 13.1M | 13.0M | 4.69M | 2.11M | ||||||
| Goodwill | 1.38M | 37.4M | 29.2M | 33.8M | 3.98M | 3.99M | 3.85M | 456.4M | 456.4M | 456.4M |
| Total assets | 203.5M | 213.6M | 254.2M | 312.1M | 148.5M | 78.9M | 29.7M | 21.4B | 22.3B | 23.0B |
| Accounts payable | 7.72M | 3.67M | 1.67M | 7.29M | 9.98M | 13.4M | 2.76M | 361.1M | 487.1M | 266.7M |
| Current liabilities | 27.7M | 36.6M | 39.5M | 57.2M | 58.7M | 47.1M | 11.9M | |||
| Long-term debt | 821.0M | 821.0M | 821.0M | |||||||
| Total debt | 2.20M | 5.77M | 2.37M | 6.65M | 491.7M | 17.1M | 1.46M | |||
| Total liabilities | 29.0M | 42.2M | 44.0M | 68.7M | 549.4M | 47.9M | 12.8M | 14.5B | 15.2B | 16.3B |
| Shareholders' equity | 174.6M | 170.4M | 206.4M | 237.1M | -400.8M | 31.0M | 16.9M | 6.90B | 7.10B | 6.77B |
| Shares outstanding | 14.1M | 13.0M | 12.2M | 5.07M | 3.70M | 7.40M | 7.40M | 0 | 0 | 56.0M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -21.8M | -28.9M | -13.8M | 14.5M | 13.4M | -2.88M | -1.88M | 318.8M | 852.6M | 827.3M |
| Capital spending | -208.0K | -1.01M | -345.0K | -4.95M | -8.55M | -2.86M | -373.9K | 0 | 0 | 0 |
| Free cash flow | -22.0M | -29.9M | -14.1M | 9.57M | 4.87M | -5.74M | -2.26M | 318.8M | 852.6M | 827.3M |
| Cash from investing | -35.8M | 38.5M | -83.0M | -46.1M | -22.0M | -5.97M | -4.60M | 295.3M | 418.0M | |
| Cash from financing | 37.5M | -3.34M | -4.70M | 143.3M | 29.3M | 11.8M | -569.1K | |||
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -190.3M | -191.0M | -200.1M |
| Share buybacks | 0 | -577.0K | -1.23M | -661.5K | 0 | 0 | ||||
| Change in cash | -20.1M | 6.32M | -101.4M | 111.7M | 20.7M | 2.99M | -7.26M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 20, 2026 | Insider trade | SEC |
| 6-K · Report of a foreign issuer | Nov 18, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Nov 17, 2026 | Current report | SEC |
| 4 · Change in ownership | Nov 5, 2026 | Insider trade | SEC |
| 6-K · Report of a foreign issuer | Nov 5, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Nov 3, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Nov 2, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Oct 13, 2026 | Current report | SEC |
| 4 · Change in ownership | Oct 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2026 | Insider trade | SEC |
Show 200 filings
This page holds 200 of 274 filings. Open Filings
Cap table
Built by 6ix from Prenetics Global Limited’s releases · as of Oct 28, 2025
- Common shares
- 17,933,272
- Fully diluted
- 17,933,272
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 17,933,272 |
Warrants and options
| Lot |
|---|
| Warrants · US$24.12 · expire about Oct 2030 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 17,933,272 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Angela Cheung | Investor Relations / Corporate Finance · Since at least Aug 26, 2026 |
| Ben Cheng | Independent Director, Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee · Since at least Nov 4, 2026 |
| Brian Chae | General Counsel · Since at least Nov 4, 2026 |
| Brian Rosin | U.S. Chief Financial Officer · Since at least Jul 10, 2026 |
| Caroline Levy | Independent Director · Since at least Nov 4, 2026 |
| Danny Sheng Wu Yeung | Chief Executive Officer, Director · Since at least Aug 20, 2026 |
| Danny Yeung | Director, Co-Founder & Chief Executive Officer · Since at least Aug 24, 2026 |
| Darshan Shah | Independent Director · Since at least Mar 26, 2026 |
| Hoi Chun Lo | Chief Financial Officer · Since at least Aug 21, 2026 |
| Hudson Leogrande | Independent Director · Since at least Jun 4, 2026 |
All 14 people
| Person | Seat |
|---|---|
| Robert Hester | VP of Growth · Since at least Nov 4, 2026 |
| Samantha Kwok | Chief of Staff, VP, Operations & People · Since at least Nov 4, 2026 |
| Senthil Sundaram | Chief Clinical Officer · Since at least Nov 4, 2026 |
| Stephen Lo | Nov 3, 2026 – Nov 3, 2026 · Past |
Log in to ask 6ix AI your own questions about Prenetics Global Limited.